Skip to main content
Top
Published in: Pediatric Nephrology 2/2005

01-02-2005 | Review

Genetic polymorphisms and risk for acute renal failure in preterm neonates

Authors: Barna Vásárhelyi, Péter Tóth-Heyn, András Treszl, Tivadar Tulassay

Published in: Pediatric Nephrology | Issue 2/2005

Login to get access

Abstract

Acute renal failure (ARF) affects about 10% of severely ill neonates. Recent studies have shown that genetic polymorphisms of proteins that play a role in neonatal physiology may contribute to individual susceptibility to both ARF and its risk factors. Our review summarizes the data collected to date. Studies have shown that the risk of preterm neonates for ARF is directly associated with a combination of high tumor necrosis factor-α producer and low interleukin-6 producer genotypes, as well as with low heat shock protein 72 producer genotype. Premature birth is itself the most important risk factor for a number of complications, including ARF, and recent studies have also shown an association between several maternal and fetal cytokine genetic polymorphisms and increased inflammatory response in preterm neonates. These polymorphisms could also be associated with increased risk for disorders such as sepsis and necrotizing enterocolitis, which lead to renal hypoperfusion and ARF. Genetic polymorphisms of the renin-angiotensin-aldosterone system have not been shown to directly influence risk for ARF. They may, however, be associated with patent ductus arteriosus, poor postnatal adaptation, and heart failure, which are all prevalent risk factors for ARF.
Literature
1.
go back to reference Guignard JP, Gouyon JB, John EG (1991) Vasoactive factors in the immature kidney. Pediatr Nephrol 5:443–446 Guignard JP, Gouyon JB, John EG (1991) Vasoactive factors in the immature kidney. Pediatr Nephrol 5:443–446
2.
go back to reference Stapleton FB, Jones DP, Green RS (1987) Acute renal failure in neonates: incidence, etiology and outcome. Pediatr Nephrol 1:314–320CrossRef Stapleton FB, Jones DP, Green RS (1987) Acute renal failure in neonates: incidence, etiology and outcome. Pediatr Nephrol 1:314–320CrossRef
3.
go back to reference Tóth-Heyn P, Drukker A, Guignard JP (2000) The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 14:227–239CrossRef Tóth-Heyn P, Drukker A, Guignard JP (2000) The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 14:227–239CrossRef
4.
go back to reference Tufro-McReddie A, Gomez RA (1993) Ontogeny of the renin-angiotensin system. Semin Nephrol 13:519–530 Tufro-McReddie A, Gomez RA (1993) Ontogeny of the renin-angiotensin system. Semin Nephrol 13:519–530
5.
go back to reference Chevalier RL (1996) Developmental renal physiology of the low birth weight pre-term newborn. J Urol 156:714–719CrossRef Chevalier RL (1996) Developmental renal physiology of the low birth weight pre-term newborn. J Urol 156:714–719CrossRef
6.
go back to reference Tack ED, Perlman JM (1988) Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 112:805–810 Tack ED, Perlman JM (1988) Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 112:805–810
7.
go back to reference Prevot A, Mosig D, Guignard JP (2002) The effects of losartan on renal function in the newborn rabbit. Pediatr Res 51:728–732CrossRef Prevot A, Mosig D, Guignard JP (2002) The effects of losartan on renal function in the newborn rabbit. Pediatr Res 51:728–732CrossRef
8.
go back to reference Guignard JP, Burgener F, Calame A (1981) Persistent anuria in a neonate: a side effect of captopril? Int J Pediatr Nephrol 2:133 Guignard JP, Burgener F, Calame A (1981) Persistent anuria in a neonate: a side effect of captopril? Int J Pediatr Nephrol 2:133
9.
go back to reference Tack ED, Perlman JM (1988) Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 112:805–810 Tack ED, Perlman JM (1988) Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 112:805–810
10.
go back to reference Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin-1-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346PubMed Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin-1-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346PubMed
11.
go back to reference Duncan JA, Scholey JW, Miller JA (2001) Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 10:111–116 Duncan JA, Scholey JW, Miller JA (2001) Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 10:111–116
12.
go back to reference Nobilis A, Kocsis I, Tóth-Heyn P, Treszl A, Schuler A, Tulassay T, Vásárhelyi B (2001) Variance of ACE and AT1 receptor gene does not influence the risk of neonatal acute renal failure. Pediatr Nephrol16:1063–1066 Nobilis A, Kocsis I, Tóth-Heyn P, Treszl A, Schuler A, Tulassay T, Vásárhelyi B (2001) Variance of ACE and AT1 receptor gene does not influence the risk of neonatal acute renal failure. Pediatr Nephrol16:1063–1066
13.
go back to reference Bender JW, Davitt MK, Jose P (1978) Angiotensin-I-converting enzyme activity in term and premature infants. Biol Neonate 34:19–23 Bender JW, Davitt MK, Jose P (1978) Angiotensin-I-converting enzyme activity in term and premature infants. Biol Neonate 34:19–23
14.
go back to reference Walther T, Faber R, Maul B, Schultheiss HP, Siems WE, Stepan H (2002) Fetal, neonatal cord, and maternal plasma concentrations of angiotensin-converting enzyme (ACE) Prenat Diagn 22:111–113 Walther T, Faber R, Maul B, Schultheiss HP, Siems WE, Stepan H (2002) Fetal, neonatal cord, and maternal plasma concentrations of angiotensin-converting enzyme (ACE) Prenat Diagn 22:111–113
15.
go back to reference Harding D, Dhamrait S, Marlow N, Whitelaw A, Gupta S, Humphries S, Montgomery H (2003) Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants. J Pediatr 143:746–749CrossRef Harding D, Dhamrait S, Marlow N, Whitelaw A, Gupta S, Humphries S, Montgomery H (2003) Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants. J Pediatr 143:746–749CrossRef
16.
go back to reference Guba M, Steinbauer M, Buchner M, Frolich D, Farkas S, Jauch KW, Anthuber M (2000) Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro. Shock 13:190–196 Guba M, Steinbauer M, Buchner M, Frolich D, Farkas S, Jauch KW, Anthuber M (2000) Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro. Shock 13:190–196
17.
go back to reference Treszl A, Szabó M, Dunai G, Nobilis A, Kocsis I, Machay T, Tulassay T, Vásárhelyi B (2003) Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates. Pediatr Res 54:753–755CrossRef Treszl A, Szabó M, Dunai G, Nobilis A, Kocsis I, Machay T, Tulassay T, Vásárhelyi B (2003) Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates. Pediatr Res 54:753–755CrossRef
18.
go back to reference Lipworth BJ, Dagg KD (1994) Vasoconstrictor effects of angiotensin II on the pulmonary vascular bed. Chest 105:1360–1364 Lipworth BJ, Dagg KD (1994) Vasoconstrictor effects of angiotensin II on the pulmonary vascular bed. Chest 105:1360–1364
19.
go back to reference Cargill RI, Lipworth BJ (1995) The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature. Br J Clin Pharmacol 40:11–18 Cargill RI, Lipworth BJ (1995) The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature. Br J Clin Pharmacol 40:11–18
20.
go back to reference Thijs A, Thijs LG (1998) Pathogenesis of renal failure in sepsis. Kidney Int 66: S34–S37 Thijs A, Thijs LG (1998) Pathogenesis of renal failure in sepsis. Kidney Int 66: S34–S37
21.
go back to reference Kohan DE (1994) Role of endothelin and tumour necrosis factor in the renal response to sepsis. Nephrol Dial Transplant 9:73–77 Kohan DE (1994) Role of endothelin and tumour necrosis factor in the renal response to sepsis. Nephrol Dial Transplant 9:73–77
22.
go back to reference Uddman E, Moller S, Adner M, Edvinsson L (1999) Cytokines induce increased endothelin ET(B) receptor-mediated contraction. Eur J Pharmacol 376:223–232CrossRef Uddman E, Moller S, Adner M, Edvinsson L (1999) Cytokines induce increased endothelin ET(B) receptor-mediated contraction. Eur J Pharmacol 376:223–232CrossRef
23.
go back to reference Nakamura M, Yoshida H, Arakawa N, Saitoh S, Satoh M, Hiramori K (2000) Effects of tumor necrosis factor-α on basal and stimulated endothelium-dependent vasomotion in human resistance vessel. J Cardiovasc Pharmacol 36:487–492CrossRef Nakamura M, Yoshida H, Arakawa N, Saitoh S, Satoh M, Hiramori K (2000) Effects of tumor necrosis factor-α on basal and stimulated endothelium-dependent vasomotion in human resistance vessel. J Cardiovasc Pharmacol 36:487–492CrossRef
24.
go back to reference Tschaikowsky K, Sagner S, Lehnert N, Kaul M, Ritter J (2000) Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines. Crit Care Med 28:1854–1860CrossRef Tschaikowsky K, Sagner S, Lehnert N, Kaul M, Ritter J (2000) Endothelin in septic patients: effects on cardiovascular and renal function and its relationship to proinflammatory cytokines. Crit Care Med 28:1854–1860CrossRef
25.
go back to reference Treszl A, Tóth-Heyn P, Kocsis I, Nobilis A, Schuler A, Tulassay T, Vásárhelyi B (2002) Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol 17:713–717CrossRef Treszl A, Tóth-Heyn P, Kocsis I, Nobilis A, Schuler A, Tulassay T, Vásárhelyi B (2002) Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol 17:713–717CrossRef
26.
go back to reference Daher S, Shulzhenko N, Morgun A, Mattar R, Rampim GF, Camano L, DeLima MG (2003) Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 58:69–77CrossRef Daher S, Shulzhenko N, Morgun A, Mattar R, Rampim GF, Camano L, DeLima MG (2003) Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 58:69–77CrossRef
27.
go back to reference Unfried G, Tempfer C, Schneeberger C, Widmar B, Nagele F, Huber JC (2001) Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 75:683–687CrossRef Unfried G, Tempfer C, Schneeberger C, Widmar B, Nagele F, Huber JC (2001) Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 75:683–687CrossRef
28.
go back to reference Reid JG, Simpson NA, Walker RG, Economidou O, Shillito J, Gooi HC, Duffy SR, Walker JJ (2001) The carriage of pro-inflammatory cytokine gene polymorphisms in recurrent pregnancy loss. Am J Reprod Immunol 45:35–40CrossRef Reid JG, Simpson NA, Walker RG, Economidou O, Shillito J, Gooi HC, Duffy SR, Walker JJ (2001) The carriage of pro-inflammatory cytokine gene polymorphisms in recurrent pregnancy loss. Am J Reprod Immunol 45:35–40CrossRef
29.
go back to reference Simhan HN, Krohn MA, Roberts JM, Zeevi A, Caritis SN (2003) Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol 189:915–918CrossRef Simhan HN, Krohn MA, Roberts JM, Zeevi A, Caritis SN (2003) Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol 189:915–918CrossRef
30.
go back to reference Treszl A, Kocsis I, Szathmári M, Schuler A, Héninger E, Tulassay T, Vásárhelyi B (2003) Genetic variants of TNF-α, IL-1beta, IL-4 receptor α-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 83:241–245CrossRef Treszl A, Kocsis I, Szathmári M, Schuler A, Héninger E, Tulassay T, Vásárhelyi B (2003) Genetic variants of TNF-α, IL-1beta, IL-4 receptor α-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants. Biol Neonate 83:241–245CrossRef
31.
go back to reference Harding D, Dhamrait S, Millar A, Humphries S, Marlow N, Whitelaw A, Montgomery H (2003) Is interleukin-6 -174 genotype associated with the development of septicemia in preterm infants? Pediatrics 112:800–803CrossRef Harding D, Dhamrait S, Millar A, Humphries S, Marlow N, Whitelaw A, Montgomery H (2003) Is interleukin-6 -174 genotype associated with the development of septicemia in preterm infants? Pediatrics 112:800–803CrossRef
32.
go back to reference Ahrens P, Kattner E, Kohler B, Hartel C, Seidenberg J, Segerer H, Moller J, Gopel W (2004) Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr Res 55:652–656CrossRef Ahrens P, Kattner E, Kohler B, Hartel C, Seidenberg J, Segerer H, Moller J, Gopel W (2004) Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr Res 55:652–656CrossRef
33.
go back to reference Treszl A, Héninger E, Kálmán A, Schuler A, Tulassay T, Vásárhelyi B (2003) Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. J Pediatr Surg 38:1374–1378CrossRef Treszl A, Héninger E, Kálmán A, Schuler A, Tulassay T, Vásárhelyi B (2003) Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. J Pediatr Surg 38:1374–1378CrossRef
34.
go back to reference Héninger E, Treszl A, Kocsis I, Dérfalvi B, Tulassay T, Vásárhelyi B (2002) Genetic variants of the interleukin-18 promoter region (-607) influence the course of necrotising enterocolitis in very low birth weight neonates. Eur J Pediatr 161:410–411CrossRef Héninger E, Treszl A, Kocsis I, Dérfalvi B, Tulassay T, Vásárhelyi B (2002) Genetic variants of the interleukin-18 promoter region (-607) influence the course of necrotising enterocolitis in very low birth weight neonates. Eur J Pediatr 161:410–411CrossRef
35.
go back to reference Treszl A, Kocsis I, Szathmári M, Schuler A, Tulassay T, Vásárhelyi B (2001) Genetic variants of the tumour necrosis factor-alpha promoter gene do not influence the development of necrotizing enterocolitis. Acta Paediatr 90:1182–1185CrossRef Treszl A, Kocsis I, Szathmári M, Schuler A, Tulassay T, Vásárhelyi B (2001) Genetic variants of the tumour necrosis factor-alpha promoter gene do not influence the development of necrotizing enterocolitis. Acta Paediatr 90:1182–1185CrossRef
36.
go back to reference Molitoris BA (1991) New insights into the cell biology of ischemic acute renal failure. J Am Soc Nephrol 1:1263–1270 Molitoris BA (1991) New insights into the cell biology of ischemic acute renal failure. J Am Soc Nephrol 1:1263–1270
37.
go back to reference Ozer EA, Yilmaz O, Akhisaroglu M, Tuna B, Bakiler AR, Ozer E. (2002) Heat shock protein 70 expression in neonatal rats after hypoxic stress. J Matern Fetal Neonatal Med 12:112–117 Ozer EA, Yilmaz O, Akhisaroglu M, Tuna B, Bakiler AR, Ozer E. (2002) Heat shock protein 70 expression in neonatal rats after hypoxic stress. J Matern Fetal Neonatal Med 12:112–117
38.
go back to reference Vicencio A, Bidmon B, Ryu J, Reidy K,·Thulin G, Mann A, Gaudio KM, Kashgarian M, Siegel NJ (2003) Developmental expression of HSP-72 and ischemic tolerance of the immature kidney. Pediatr Nephrol 18:85–91 Vicencio A, Bidmon B, Ryu J, Reidy K,·Thulin G, Mann A, Gaudio KM, Kashgarian M, Siegel NJ (2003) Developmental expression of HSP-72 and ischemic tolerance of the immature kidney. Pediatr Nephrol 18:85–91
39.
go back to reference Pociot F, Ronningen KS, Nerup J (1993) Polymorphic analysis of the human MHC-linked heat shock protein 70 (HSP70–2) and HSP70-Hom genes in insulin-dependent diabetes mellitus (IDDM). Scand J Immunol 38:491–495PubMed Pociot F, Ronningen KS, Nerup J (1993) Polymorphic analysis of the human MHC-linked heat shock protein 70 (HSP70–2) and HSP70-Hom genes in insulin-dependent diabetes mellitus (IDDM). Scand J Immunol 38:491–495PubMed
40.
go back to reference Fekete A, Treszl A, Tóth-Heyn P, Vannay A, Tordai A, Tulassay T, Vásárhelyi B (2003) Association between heat shock protein 72 gene polymorphism and acute renal failure in premature neonates. Pediatr Res 54:452–455CrossRef Fekete A, Treszl A, Tóth-Heyn P, Vannay A, Tordai A, Tulassay T, Vásárhelyi B (2003) Association between heat shock protein 72 gene polymorphism and acute renal failure in premature neonates. Pediatr Res 54:452–455CrossRef
Metadata
Title
Genetic polymorphisms and risk for acute renal failure in preterm neonates
Authors
Barna Vásárhelyi
Péter Tóth-Heyn
András Treszl
Tivadar Tulassay
Publication date
01-02-2005
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 2/2005
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1711-x

Other articles of this Issue 2/2005

Pediatric Nephrology 2/2005 Go to the issue